Cargando…
Corrigendum: Differential biodistribution of adenoviral-vectored vaccine following intranasal and endotracheal deliveries leads to different immune outcomes
Autores principales: | Jeyanathan, Vidthiya, Afkhami, Sam, D’Agostino, Michael R., Zganiacz, Anna, Feng, Xueya, Miller, Matthew S., Jeyanathan, Mangalakumari, Thompson, Michael R., Xing, Zhou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941987/ https://www.ncbi.nlm.nih.gov/pubmed/36825013 http://dx.doi.org/10.3389/fimmu.2023.1151809 |
Ejemplares similares
-
Differential Biodistribution of Adenoviral-Vectored Vaccine Following Intranasal and Endotracheal Deliveries Leads to Different Immune Outcomes
por: Jeyanathan, Vidthiya, et al.
Publicado: (2022) -
Adenoviral-vectored next-generation respiratory mucosal
vaccines against COVID-19
por: Afkhami, Sam, et al.
Publicado: (2023) -
Intranasal multivalent adenoviral-vectored vaccine protects against replicating and dormant M.tb in conventional and humanized mice
por: Afkhami, Sam, et al.
Publicado: (2023) -
Design Considerations for Intratracheal Delivery Devices to Achieve Proof-of-Concept Dry Powder Biopharmaceutical Delivery in Mice
por: Manser, Myla, et al.
Publicado: (2023) -
Mucosal-Pull Induction of Lung-Resident Memory CD8 T Cells in Parenteral TB Vaccine-Primed Hosts Requires Cognate Antigens and CD4 T Cells
por: Haddadi, Siamak, et al.
Publicado: (2019)